BioCryst Pharmaceuticals
BCRX
#4677
Rank
A$2.54 B
Marketcap
$12.18
Share price
-2.16%
Change (1 day)
49.09%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - P/B ratio

P/B ratio as of March 2025 : -3.50

According to BioCryst Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 3.9707.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioCryst Pharmaceuticals - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31-3.4126.55%
2023-12-31-2.69-62.93%
2022-12-31-7.26-68.81%
2021-12-31-23.3-65.89%
2020-12-31-68.3-591.41%
2019-12-3113.9-22.97%
2018-12-3118.0212.76%
2017-12-315.77-98.05%
2016-12-312961765.24%
2015-12-3115.937.12%
2014-12-3111.6-102.9%
2013-12-31-399150.56%
2012-12-31-159-2210.4%
2011-12-317.54112.56%
2010-12-313.557.92%
2009-12-313.29191.24%
2008-12-311.13-68.77%
2007-12-313.62-77.38%
2006-12-3116.093.53%
2005-12-318.2692.63%
2004-12-314.29-0.37%
2003-12-314.30918.74%
2002-12-310.4224

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
4.33-223.78%๐Ÿ‡บ๐Ÿ‡ธ USA
8.30-337.38%๐Ÿ‡บ๐Ÿ‡ธ USA
1.90-154.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.54-27.42%๐Ÿ‡บ๐Ÿ‡ธ USA
7.99-328.45%๐Ÿ‡บ๐Ÿ‡ธ USA
1.81-151.82%๐Ÿ‡บ๐Ÿ‡ธ USA
4.56-230.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
0.6199-117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
2.36-167.41%๐Ÿ‡บ๐Ÿ‡ธ USA